Shares of Kuros Biosciences AG are listed on the SIX Swiss Exchange
SIX Swiss Exchange: KURN
Bloomberg: KURN SW
Reuters: KURN.S
CH0325814116
Kuros reports financial results in US dollars using International Financial Reporting Standards (IFRS).
PricewaterhouseCoopers AG serves as our independent registered public accounting firm. Auditor selection is approved annually by shareholder vote.
Yes. Kuros uses equity-based compensation to attract and retain top talent while aligning leadership and shareholder interests. A stock incentive plan is in place for employees and directors.
January 1 to December 31
No, the company reinvests its earnings to support future growth and innovation.
Switzerland
Register to receive press releases and investor news here.